Annual Current Assets
$742.05 M
-$110.03 M-12.91%
December 31, 2023
Summary
- As of February 8, 2025, PACB annual total current assets is $742.05 million, with the most recent change of -$110.03 million (-12.91%) on December 31, 2023.
- During the last 3 years, PACB annual current assets has risen by +$386.46 million (+108.68%).
- PACB annual current assets is now -32.61% below its all-time high of $1.10 billion, reached on December 31, 2021.
Performance
PACB Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$584.23 M
-$43.91 M-6.99%
September 30, 2024
Summary
- As of February 8, 2025, PACB quarterly total current assets is $584.23 million, with the most recent change of -$43.91 million (-6.99%) on September 30, 2024.
- Over the past year, PACB quarterly current assets has dropped by -$43.91 million (-6.99%).
- PACB quarterly current assets is now -51.15% below its all-time high of $1.20 billion, reached on March 31, 2021.
Performance
PACB Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
PACB Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.9% | -7.0% |
| 3 y3 years | +108.7% | -48.3% |
| 5 y5 years | +463.6% | +659.3% |
PACB Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.6% | at low | -46.9% | at low |
| 5 y | 5-year | -32.6% | +815.6% | -51.1% | +620.9% |
| alltime | all time | -32.6% | +815.6% | -51.1% | +659.3% |
Pacific Biosciences Of California Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $584.23 M(-7.0%) |
| Jun 2024 | - | $628.14 M(-7.2%) |
| Mar 2024 | - | $677.02 M(-8.8%) |
| Dec 2023 | $1.00 B(+9.7%) | $742.05 M(-15.9%) |
| Sep 2023 | - | $882.30 M(-5.7%) |
| Jun 2023 | - | $935.55 M(-4.6%) |
| Mar 2023 | - | $981.11 M(+15.1%) |
| Dec 2022 | $915.01 M(+1.0%) | $852.07 M(-6.8%) |
| Sep 2022 | - | $913.90 M(-5.8%) |
| Jun 2022 | - | $970.29 M(-5.7%) |
| Mar 2022 | - | $1.03 B(-6.5%) |
| Dec 2021 | $905.84 M(+1451.3%) | $1.10 B(-2.5%) |
| Sep 2021 | - | $1.13 B(-5.0%) |
| Jun 2021 | - | $1.19 B(-0.6%) |
| Mar 2021 | - | $1.20 B(+236.3%) |
| Dec 2020 | $58.39 M(-12.8%) | $355.59 M(+48.5%) |
| Sep 2020 | - | $239.51 M(+58.7%) |
| Jun 2020 | - | $150.94 M(-11.0%) |
| Mar 2020 | - | $169.53 M(+109.2%) |
| Dec 2019 | $66.94 M(+73.3%) | $81.05 M(+5.3%) |
| Sep 2019 | - | $76.94 M(-22.2%) |
| Jun 2019 | - | $98.91 M(-12.1%) |
| Mar 2019 | - | $112.59 M(-14.5%) |
| Dec 2018 | $38.62 M(-9.1%) | $131.66 M(-8.5%) |
| Sep 2018 | - | $143.87 M(+49.2%) |
| Jun 2018 | - | $96.41 M(-16.7%) |
| Mar 2018 | - | $115.70 M(+13.9%) |
| Dec 2017 | $42.47 M | $101.62 M(-10.6%) |
| Sep 2017 | - | $113.61 M(-14.5%) |
| Jun 2017 | - | $132.93 M(+50.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $88.34 M(-19.0%) |
| Dec 2016 | $28.87 M(+40.4%) | $109.01 M(-11.0%) |
| Sep 2016 | - | $122.47 M(-11.3%) |
| Jun 2016 | - | $138.06 M(+16.0%) |
| Mar 2016 | - | $119.05 M(+7.7%) |
| Dec 2015 | $20.57 M(+210.2%) | $110.54 M(+28.2%) |
| Sep 2015 | - | $86.21 M(-4.4%) |
| Jun 2015 | - | $90.19 M(-9.4%) |
| Mar 2015 | - | $99.52 M(-15.5%) |
| Dec 2014 | $6.63 M(-31.8%) | $117.76 M(+3.2%) |
| Sep 2014 | - | $114.14 M(-4.8%) |
| Jun 2014 | - | $119.90 M(-9.2%) |
| Mar 2014 | - | $132.06 M(+4.4%) |
| Dec 2013 | $9.73 M(-33.8%) | $126.46 M(-10.8%) |
| Sep 2013 | - | $141.76 M(+16.1%) |
| Jun 2013 | - | $122.11 M(-3.5%) |
| Mar 2013 | - | $126.48 M(+10.0%) |
| Dec 2012 | $14.68 M(-21.5%) | $115.00 M(-13.1%) |
| Sep 2012 | - | $132.34 M(-13.3%) |
| Jun 2012 | - | $152.64 M(-13.7%) |
| Mar 2012 | - | $176.81 M(-11.4%) |
| Dec 2011 | $18.71 M(+48.1%) | $199.60 M(-9.4%) |
| Sep 2011 | - | $220.28 M(-10.0%) |
| Jun 2011 | - | $244.73 M(-7.4%) |
| Mar 2011 | - | $264.27 M(-9.8%) |
| Dec 2010 | $12.63 M(+71.8%) | $293.11 M(+149.9%) |
| Sep 2010 | - | $117.29 M(-16.2%) |
| Jun 2010 | - | $140.01 M(+49.3%) |
| Dec 2009 | $7.35 M(+19.0%) | $93.75 M |
| Dec 2008 | $6.18 M | - |
FAQ
- What is Pacific Biosciences of California annual total current assets?
- What is the all time high annual current assets for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual current assets year-on-year change?
- What is Pacific Biosciences of California quarterly total current assets?
- What is the all time high quarterly current assets for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly current assets year-on-year change?
What is Pacific Biosciences of California annual total current assets?
The current annual current assets of PACB is $742.05 M
What is the all time high annual current assets for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual total current assets is $1.10 B
What is Pacific Biosciences of California annual current assets year-on-year change?
Over the past year, PACB annual total current assets has changed by -$110.03 M (-12.91%)
What is Pacific Biosciences of California quarterly total current assets?
The current quarterly current assets of PACB is $584.23 M
What is the all time high quarterly current assets for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly total current assets is $1.20 B
What is Pacific Biosciences of California quarterly current assets year-on-year change?
Over the past year, PACB quarterly total current assets has changed by -$43.91 M (-6.99%)